Company Overview

Company name: Greenwich Biosciences
Description: Developer of cannabis-derived pharmaceutical medicines intended to transform the lives of seriously ill patients. The company explores a variety of therapeutic areas such as neurology, oncology, psychiatry and autism spectrum disorders, helping children and adults with severe, life-threatening forms of epilepsy.
Year founded: 2015
Parent company:
Industry: Healthcare | Group: | Code:
City: Carlsbad
State: California
Country: United States

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status:
Number of active investors:
Profile last updated: 24-Feb-2020
Last known valuation:
Last known valuation date: